- Value Creation: While financial returns are paramount, we are strong proponents of value creation for our portfolio by driving innovation, expanding market share, enhancing competitive advantage, and unlocking new growth avenues.
- Synergies and Collaboration: Science does not thrive in silos, so it is crucial to build collaborative partnerships and explore synergies between investors and investee companies.
- Long-Term Vision: Alignment on the best exit strategies for start-ups is important in the initial stages. Not only does it bring a long-term perspective but also creates a collective commitment to sustainable growth.
- Industry Expertise: Given the length and breadth of Lifesciences industry, tapping into the experience and expertise of seasoned scientists, veterans and mentors is key to creating successful enterprises.
Just like it takes a village to raise a child, it takes an ecosystem to nurture a start-up. And we bring just that to our portfolio companies through PoweRx, an ensemble of niche Lifesciences and Healthcare businesses within our parent group, JV Ventures.
Through Rx Propellant, a leading Lifesciences infrastructure platform, we provide our portfolio companies access to compliant R&D labs in key clusters across India. On the other hand, start-ups can maintain lean operations by leveraging GVRP, a bespoke in-house CRO, for chemistry/biology services and dedicated CoE setup. Furthermore, they can benefit from GV Connect, a non-profit networking platform for the scientific community for forging partnerships and collaborations.
The vibrant PoweRx ecosystem with diverse businesses, clientele and partners also channels new investment and co-creation opportunities into the Fund.
One West Terminus, Gate 3, 24th floor, Nanakaramguda , Financial District, Telangana, Hyderabad - 500008, India
